Results 271 to 280 of about 8,468,954 (280)

Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings

Ca-A Cancer Journal for Clinicians, 2006
Melissa McDiarmid, Thomas H Connor
exaly  

DGIdb 2.0: Mining Clinically Relevant Drug-Gene Interactions.

Nucleic Acids Research, 2016
Katie M Campbell, Jason R Walker, Benjamin J Ainscough   +2 more
exaly  

Oncogenes and Tumor Suppressor Genes

Ca-A Cancer Journal for Clinicians, 1994
Robert Weinberg
exaly  

Cancer Patients at Risk of Drug Interactions

Ca-A Cancer Journal for Clinicians, 2007
exaly  

Food and Drug Administration, Partner in Drug Development

Ca-A Cancer Journal for Clinicians, 2006
Jérôme W Yates, J W Yates
exaly  

CYP2D6 Drug-Gene and Drug-Drug-Gene Interactions Among Patients Prescribed Pharmacogenetically Actionable Opioids

Applied Nursing Research, 2017
Claire Burke-Draucker, Mitchell R Knisely, Diane Von Ah   +2 more
exaly  

Pharmacoepigenomics

Medical Epigenetics, 2016
exaly  

How Common Are Drug and Gene Interactions? Prevalence in a Sample of 1143 Patients With CYP2C9, CYP2C19 and CYP2D6 Genotyping

Pharmacogenomics, 2014
exaly  

CRISPR- Engineered Cytochrome P450 CYP3A5 Cell Models to Advance Tacrolimus Precision Dosing and Drug-Drug-Gene Interaction Studies (Abstract ID: 228552)

The Journal of Pharmacology and Experimental Therapeutics
Kohinoor Khan, Rory P. Remmel, Sarah Elmer, Duy Vo, William S. Oetting, Ajay K. Israni, Pamala A. Jacobson, Casey R. Dorr   +7 more
openaire   +1 more source

Pharmacogenomic Actionability Is a Clinical State, Not a Genotype Label: Integrating Phenoconversion, Drug–Drug–Gene Interactions, Competing Risks, and Guideline Discordance in Precision Prescribing

Annals of Pharmacy Practice and Pharmacotherapy
Sofía Martínez, Carlos Gómez, Lucia Navarro   +2 more
openaire   +1 more source